Glutathione treatments involve a standard IV insertion, which may cause minor discomfort to some patients
Vitamin B12 is water-soluble, which means the body takes what it needs, and the rest passes harmlessly through the body
Trade-offs: Stims = fast appetite suppression, CV side effects and tolerance risk
The study discussed here was relatively small, involving only 17 patients, and more extensive clinical trials are needed to fully understand: Long-term safety profile Optimal dosing protocols Patient selection criteria Potential side effects Interactions with other treatments Additionally, patients should be aware that BPC-157 is not yet FDA-approved for human use, and treatment is typically offered on a research or compassionate use basis by qualified practitioners
The dual-peptide approach costs $500-900 monthly for research peptides or will likely run $1,200-1,500 monthly for pharmaceutical CagriSema once FDA approved